HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 21 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $509,736 | +258649.2% | 656,453 | 0.0% | 0.00% | – |
| Q4 2022 | $197 | -99.9% | 656,453 | -0.3% | 0.00% | – |
| Q3 2022 | $332,000 | -11.7% | 658,110 | 0.0% | 0.00% | – |
| Q2 2022 | $376,000 | -55.7% | 658,110 | 0.0% | 0.00% | – |
| Q1 2022 | $848,000 | +13.1% | 658,110 | 0.0% | 0.00% | – |
| Q4 2021 | $750,000 | -25.4% | 658,110 | 0.0% | 0.00% | – |
| Q3 2021 | $1,006,000 | -22.0% | 658,110 | +1.0% | 0.00% | – |
| Q2 2021 | $1,289,000 | +19.0% | 651,318 | +10.6% | 0.00% | – |
| Q1 2021 | $1,083,000 | +144.5% | 588,718 | +190.6% | 0.00% | – |
| Q4 2020 | $443,000 | +804.1% | 202,555 | +1183.1% | 0.00% | – |
| Q3 2020 | $49,000 | -66.9% | 15,786 | -43.3% | 0.00% | – |
| Q4 2019 | $148,000 | – | 27,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 923,230 | $2,022,000 | 0.82% |
| Worth Venture Partners, LLC | 233,947 | $512,000 | 0.40% |
| PERKINS CAPITAL MANAGEMENT INC | 150,000 | $329,000 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 89,067 | $195,000 | 0.03% |
| PREMIER ASSET MANAGEMENT LLC | 70,000 | $153,000 | 0.03% |
| Allen Capital Group, LLC | 23,685 | $52,000 | 0.01% |
| ZEKE CAPITAL ADVISORS, LLC | 50,000 | $110,000 | 0.01% |
| Prospera Financial Services Inc | 39,300 | $86,000 | 0.01% |
| Onex Canada Asset Management Inc. | 20,000 | $44,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 95,300 | $208,000 | 0.00% |